Chromogenicin situhybridization (CISH) to detectHER2gene amplification in breast and gastric cancer: Comparison with immunohistochemistry (IHC) and fluorescencein situhybridization (FISH)

The CRKL gene encoding an adaptor protein is amplified, overexpressed, and a possible therapeutic target in gastric cancer

(2012) Hiroko Natsume et al.   Journal of Translational Medicine

Detection of kinase amplifications in gastric cancer archives using fluorescence in situ hybridization

(2012) Shin-ichiro Kiyose et al.   PATHOLOGY INTERNATIONAL

Correlations of TOP2A gene aberrations and expression of topoisomerase IIα protein and TOP2A mRNA expression in primary breast cancer: A retrospective study of 86 cases using fluorescence in situ hybridization and immunohistochemistry

(2012) Hui Meng et al.   PATHOLOGY INTERNATIONAL

Reduced expression of MUTYH with suppressive activity against mutations caused by 8-hydroxyguanine is a novel predictor of a poor prognosis in human gastric cancer

(2011) Kazuya Shinmura et al.   JOURNAL OF PATHOLOGY

Low frequency of HER2 amplification and overexpression in early onset gastric cancer

(2011) Cathy B. Moelans et al.   CELLULAR ONCOLOGY

A study of HER2 gene amplification and protein expression in gastric cancer

(2010) B. Yan et al.   JOURNAL OF CLINICAL PATHOLOGY

Targeted HER2 Treatment in Advanced Gastric Cancer

(2010) Jan Trøst Jørgensen   ONCOLOGY

Evaluation of HER2 gene amplification in invasive breast cancer using a dual-color chromogenic in situ hybridization (dual CISH)

(2010) Nobuaki Kato et al.   PATHOLOGY INTERNATIONAL

Fluorescence in situ hybridization analysis with a tissue microarray: ‘FISH and chips’ analysis of pathology archives

(2010) Haruhiko Sugimura et al.   PATHOLOGY INTERNATIONAL

Detection of chromosome changes in pathology archives: an application of microwave-assisted fluorescence in situ hybridization to human carcinogenesis studies

(2008) Haruhiko Sugimura   CARCINOGENESIS